S-EPMC11147753 - Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations. - OmicsDI

Unknown

Dataset Information

Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations.

ABSTRACT:

SUBMITTER: Curik N

PROVIDER: S-EPMC11147753 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature